Anatomic Pathology Market Size, Share & Trends Analysis Report By Product & Services (Consumables, Instruments, Services), By Application, By End-use, By Region, And Segment Forecasts, 2021 - 2028

Anatomic Pathology Market Growth & Trends
The global anatomic pathology market size is expected to reach USD 34.66 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 10.08% from 2021 to 2028. The advent of technology in the instruments and the protocols used during the anatomic pathological procedures is anticipated to increase the adoption rate of advanced anatomic pathological instruments.

Market players are collaborating for the refurbishment of pathology products by the incorporation of innovative disease diagnostic models. In April 2021, Leica Biosystems collaborated with Paige, an AI-based diagnostics company, for expanded access to computational pathology products for translational and clinical research. Under this partnership, Paige’s AI-enabled research software and Leica Biosystems’ digital pathology platform were combined. This, in turn, accelerates investments in the up-gradation of pathological equipment.

Pathology-training programs offered to pathologist trainees by public and private entities drive the market. For instance, the Accreditation Council for Graduate Medical Education accredited residency programs for anatomic pathology provide education and training to individuals via numerous teaching conferences.

The drug discovery and development application segment are expected to witness the fastest growth over the forecast period due to the shifting paradigm from conventional medicine to personalized medicine. This is primarily due to the growing reliance on discoveries of putative biomarkers for the development of personalized therapies. Ongoing pathology training programs to ensure that the pathology residents are aware of the developments taking place in the field of personalized medicine have also accelerated the market growth.

North America held the largest revenue share in 2020 owing to a large number of funding programs by public agencies and the presence of key players. Asia Pacific is expected to witness the fastest growth due to the presence of multiple associations that are engaged in conducting pathology training programs.

Key players are undertaking various strategic initiatives such as mergers & acquisitions and new product development to maintain their market presence. For instance, in May 2021, CellCarta acquired Reveal Biosciences, an AI-based pathology firm. This acquisition is aimed at expanding CellCarta’s offerings in AI-enabled multi-omic data analysis services and applications.

Anatomic Pathology Market Report Highlights

  • By product and services, the consumables segment accounted for the largest share in 2020. High availability, low cost, and a frequent purchase rate of consumables contributed to the segment growth
  • The instruments product and services segment is expected to witness the fastest growth over the forecast period. Technological advancements in instruments to minimize the risk of errors through the integration of novel design are expected to drive the segment
  • The disease diagnosis application segment dominated the market in 2020 owing to the increasing role of anatomic pathological tools in identifying any anomalies that help diagnose a condition. The use of biomarkers for tracking and identifying infections and diseases during diagnostic processes is expected to boost the growth of the segment
  • In terms of end use, the hospitals segment captured the largest share in 2020 due to an increase in the hospitalization rate that stimulates the adoption of pathological workflows for disease monitoring and diagnosis
  • The diagnostic laboratories end-use segment growth is facilitated by the use of state-of-the-art laboratory equipment and instrumentation, multiple electronic interfaces, and information systems
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1 Methodology And Scope
1.1 Research Assumptions
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Sample size for the study on anatomic pathology market:
1.3.1.1 Service Providers:
Details of Primary Research
1.3.1.2 Secondary Data Sources:
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Global Market: CAGR Calculation
1.7 Objectives
1.7.1 OBJECTIVE 1:
1.7.2 OBJECTIVE 2:
Chapter 2 Executive Summary
2.1 Market Summary, 2020
2.2 Market Segmentation
2.3 Anatomic Pathology Competitive Insights
Chapter 3 Market Variables, Trends, & Scope
3.1 Market Trends & Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Implementation of biomarker-based disease assessments
3.2.1.2 Rising competitiveness among the market vendors
3.2.1.3 Substantial number of supporting programs and training modules by government
3.2.1.4 Rising incidence of chronic disorders
3.2.2 Market Restraint Analysis
3.2.2.1 Stringent government regulations pertaining to anatomic pathology
3.2.2.2 Cognitive or identification errors in anatomic pathology analytic processes
3.3 Penetration and Growth Prospect Mapping for Anatomic Pathology Instruments, 2020 (USD Million)
3.4 COVID-19 Impact Analysis
3.5 Business Environment Analysis
3.5.1 SWOT analysis; by factor (Political & Legal, Economic, and Technological)
3.5.2 Porter’s five forces analysis
3.6 Anatomic Pathology Market: Clinical Trials
3.7 Anatomic Pathology Market: Patent Analysis
3.8 Reimbursement Framework: Anatomic Pathology
3.9 Anatomic Pathology Market Regulatory Insights
3.9.1 United Kingdom Accreditation Service (UKAS):
3.9.2 Medicines And Healthcare Products Regulatory Agency (MHRA)
3.9.3 The Royal College Of Pathologists
3.9.4 NationaL Pathology Accreditation Advisory Council (NPAAC)
3.10 Anatomic Pathology Market: User Perspective Analysis
3.10.1 Consumer behaviour analysis
3.11 Anatomic Pathology Market: Procedure Cost Analysis
3.12 Anatomic Pathology Market: Technology Timeline
3.13 Major Deals & Strategic Alliances Analysis
3.13.1 Agreements
3.13.2 Technology collaborations
3.13.3 Mergers & acquisitions
3.13.4 Licensing & partnership
Chapter 4 Competitive Analysis
4.1 Company Categorization
4.2 Recent Developments & Impact Analysis, by Key Market Participants
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.3.1.1 Enzifarma
4.3.1.2 Abacus ALS
4.3.1.3 Sanbio B.V.
4.3.1.4 Syntec Scientific
4.3.1.5 VWR International, LLC
4.3.1.6 MetaGene Pty Ltd.
4.3.1.7 Immuno Diagnostic OY
4.3.1.8 DSS Imagetech
4.3.1.9 Fisher Scientific
4.3.1.10 IEPSA Diagnostics
4.3.2 Key customers
4.3.3 Key player positioning analysis, 2020
4.3.3.1 Number of products
4.3.3.2 Market penetration
4.3.3.3 Strategic initiatives
4.3.3.4 Segment Coverage
4.3.3.5 Geographical presence
4.3.3.6 Conclusion
Chapter 5 Product & Services Business Analysis
5.1 Anatomic Pathology Market: Product & Services Movement Analysis
5.2 Instruments
5.2.1 Global anatomic pathology instruments market estimates and forecast, 2017 - 2028 (USD Million)
5.2.2 Microtome & Cryostat
5.2.2.1 Global microtome & cryostat market for anatomic pathology, 2017 - 2028 (USD Million)
5.2.3 Tissue Processor
5.2.3.1 Global Tissue Processor market for anatomic pathology, 2017 - 2028 (USD Million)
5.2.4 Automatic Stainers
5.2.4.1 Global Automatic Stainers market for anatomic pathology, 2017 - 2028 (USD Million)
5.2.5 Whole Slide Imaging (WSI) Scanners
5.2.5.1 Global Whole Slide Imaging (WSI) Scanners market for anatomic pathology, 2017 - 2028 (USD Million)
5.2.6 Other Products
5.2.6.1 Global other products market for anatomic pathology, 2017 - 2028 (USD Million)
5.3 Consumables
5.3.1 Global anatomic pathology consumables market estimates and forecast, 2017 - 2028 (USD Million)
5.3.2 Reagents & Antibodies
5.3.2.1 Global reagents & antibodies market for anatomic pathology, 2017 - 2028 (USD Million)
5.3.3 Probes & Kits
5.3.3.1 Global Probes & kits market for anatomic pathology, 2017 - 2028 (USD Million)
5.3.4 Other Consumables
5.3.4.1 Global other consumables market for anatomic pathology, 2017 - 2028 (USD Million)
5.4 Services
5.4.1 Global anatomic pathology services market estimates and forecast, 2017 - 2028 (USD Million)
Chapter 6 Application Business Analysis
6.1 Anatomic Pathology Market: Application Movement Analysis
6.2 Disease Diagnosis
6.2.1 Anatomic pathology market estimates and forecast for disease diagnosis, 2017 - 2028 (USD Million)
6.3 Drug Discovery and Development
6.3.1 Anatomic pathology market estimates and forecast for drug discovery and development, 2017 - 2028 (USD Million)
6.4 Others
6.4.1 Anatomic pathology market for other applications, 2017 - 2028 (USD Million)
Chapter 7 End-Use Business Analysis
7.1 Anatomic Pathology Market: End-use Movement Analysis
7.2 Hospitals
7.2.1 Anatomic pathology market for hospitals, 2017 - 2028 (USD Million)
7.3 Research Laboratories
7.3.1 Anatomic pathology market for research laboratories, 2017 - 2028 (USD Million)
7.4 Diagnostic Laboratories
7.4.1 Anatomic pathology market for diagnostic laboratories, 2017 - 2028 (USD Million)
7.5 Others
7.5.1 Anatomic pathology market for other end use, 2017 - 2028 (USD Million)
Chapter 8 Regional Business Analysis
8.1 Anatomic Pathology Market: Regional Movement Analysis
8.2 North America
8.2.1 North America Anatomic Pathology Market, 2017 - 2028 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. anatomic pathology market, by product & services, 2017 - 2028 (USD Million)
8.2.2.2 U.S. anatomic pathology market, by application, 2017 - 2028 (USD Million)
8.2.2.3 U.S. anatomic pathology market, by end use, 2017 - 2028 (USD Million)
8.2.3 Canada
8.2.3.1 Canada anatomic pathology market, by product & services, 2017 - 2028 (USD Million)
8.2.3.2 Canada anatomic pathology market, by application, 2017 - 2028 (USD Million)
8.2.3.3 Canada anatomic pathology market, by end use, 2017 - 2028 (USD Million)
8.3 Europe
8.3.1 Europe Anatomic Pathology Market, 2017 - 2028 (USD Million)
8.3.2 Germany
8.3.2.1 Germany anatomic pathology market, by product & services, 2017 - 2028 (USD Million)
8.3.2.2 Germany anatomic pathology market, by application, 2017 - 2028 (USD Million)
8.3.2.3 Germany anatomic pathology market, by end use, 2017 - 2028 (USD Million)
8.3.3 U.K.
8.3.3.1 U.K. anatomic pathology market, by product & services, 2017 - 2028 (USD Million)
8.3.3.2 U.K. anatomic pathology market, by application, 2017 - 2028 (USD Million)
8.3.3.3 U.K. anatomic pathology market, by end use, 2017 - 2028 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Anatomic Pathology Market, 2017 - 2028 (USD Million)
8.4.2 China
8.4.2.1 China anatomic pathology market, by product & services, 2017 - 2028 (USD Million)
8.4.2.2 China anatomic pathology market, by application, 2017 - 2028 (USD Million)
8.4.2.3 China anatomic pathology market, by end use, 2017 - 2028 (USD Million)
8.4.3 India
8.4.3.1 India anatomic pathology market, by product & services, 2017 - 2028 (USD Million)
8.4.3.2 India anatomic pathology market, by application, 2017 - 2028 (USD Million)
8.4.3.3 India anatomic pathology market, by end use, 2017 - 2028 (USD Million)
8.5 Latin America
8.5.1 Latin America Anatomic Pathology Market, 2017 - 2028 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil anatomic pathology market, by product & services, 2017 - 2028 (USD Million)
8.5.2.2 Brazil anatomic pathology market, by application, 2017 - 2028 (USD Million)
8.5.2.3 Brazil anatomic pathology market, by end use, 2017 - 2028 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico anatomic pathology market, by product & services, 2017 - 2028 (USD Million)
8.5.3.2 Mexico anatomic pathology market, by application, 2017 - 2028 (USD Million)
8.5.3.3 Mexico anatomic pathology market, by end use, 2017 - 2028 (USD Million)
8.6 MEA
8.6.1 Middle East & Africa Anatomic Pathology Market, 2017 - 2028 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa anatomic pathology market, by product & services, 2017 - 2028 (USD Million)
8.6.2.2 South Africa anatomic pathology market, by application, 2017 - 2028 (USD Million)
8.6.2.3 South Africa anatomic pathology market, by end use, 2017 - 2028 (USD Million)
Chapter 9 Competitive Landscape
9.1 Strategy Framework
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 DANAHER CORPORATION
9.3.1.1 Company overview
9.3.1.2 Leica Microsystems
9.3.1.2.1 Company overview
9.3.1.3 Financial performance
9.3.1.4 Product benchmarking
9.3.1.5 Strategic initiatives
9.3.2 PHC HOLDINGS CORPORATION
9.3.2.1 Company overview
9.3.2.2 Epredia (Thermo Fisher Scientific’s Anatomic Pathology Business)
9.3.2.2.1 Company overview
9.3.2.3 Financial performance: PHC Holdings Corporation
9.3.2.4 Financial performance: Thermo Fisher Scientific
9.3.2.5 Product benchmarking
9.3.2.6 Strategic initiatives
9.3.3 QUEST DIAGNOSTICS INCORPORATED
9.3.3.1 Company overview
9.3.3.2 Financial performance
9.3.3.3 Product benchmarking
9.3.3.4 Strategic initiatives
9.3.4 LABORATORY CORPORATION OF AMERICA HOLDINGS
9.3.4.1 Company overview
9.3.4.2 Financial performance
9.3.4.3 Product benchmarking
9.3.4.4 Strategic initiatives
9.3.5 F. HOFFMANN-LA ROCHE LTD.
9.3.5.1 Company overview
9.3.5.2 Ventana Medical Systems, Inc.
9.3.5.2.1 Company overview
9.3.5.3 Financial performance
9.3.5.4 Product benchmarking
9.3.5.5 Strategic initiatives
9.3.6 AGILENT TECHNOLOGIES, INC.
9.3.6.1 Company overview
9.3.6.2 Financial performance
9.3.6.3 Product benchmarking
9.3.6.4 Strategic initiatives
9.3.7 CARDINAL HEALTH
9.3.7.1 Company overview
9.3.7.2 Financial performance
9.3.7.3 Product benchmarking
9.3.8 SAKURA FINETEK USA, INC.
9.3.8.1 Company overview
9.3.8.2 Financial performance
9.3.8.3 Product benchmarking
9.3.8.4 Strategic initiatives
9.3.9 NEOGENOMICS, INC
9.3.9.1 Company overview
9.3.9.2 Financial performance
9.3.9.3 Product benchmarking
9.3.9.4 Strategic initiatives
9.3.10 BIOGENEX
9.3.10.1 Company overview
9.3.10.2 Financial performance
9.3.10.3 Product benchmarking
9.3.10.4 Strategic initiatives
9.3.11 BIO SB
9.3.11.1 Company overview
9.3.11.2 Financial performance
9.3.11.3 Product benchmarking
9.3.11.4 Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings